Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fatty liver disease: a new biobank aims to unlock the secrets of a silent epidemic

NCT ID NCT07051863

Recruiting now Knowledge-focused Sponsor: Fondazione Epatocentro Ticino Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study creates a large database and biobank of people with nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. Researchers will collect medical data and biological samples over time to study how the disease develops, progresses, and responds to treatments. The goal is to enable future studies that could lead to better diagnosis and care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this biobank could help researchers identify new risk factors, biomarkers, and potential treatments for fatty liver disease.
What could go wrong
This is an observational study, not a treatment trial. It collects data for future research, so it will not directly test any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MASH NAFLD NASH/MASH

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Fondazione Epatocentro Ticino

    RECRUITING

    Lugano, Canton Ticino, 6900, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.